Header image

Closing Plenary Session

Wednesday, November 11, 2026
3:30 PM - 4:30 PM
Pleiades

Speaker

APSAD 2026

Poster Prizes

3:30 PM - 3:45 PM

APSAD 2026

Late Breaker Prizes

3:45 PM - 4:00 PM

Agenda Item Image
Miss Grace Oh
Director
Australian Drug Education & Consultancy

Closing Remarks

4:00 PM - 4:10 PM

Grace Oh is Director at Australian Drug Education & Consultancy, a seasonal lecturer with Edith Cowan University, and proudly serves as Western Australia’s representative on the APSAD Council Board. With over 25 years in the alcohol and other drug sector, Grace’s career reflects her commitment to bridging evidence and practice, delivering contemporary workforce development and designing innovative peer, treatment, and harm reduction initiatives throughout WA. A passion for overdose prevention, early warning systems, drug checking, and safer festival events powers her advocacy. Grace’s contributions have earned her recognition, including the Inaugural APSAD Advocacy Award in 2021, which celebrates her leadership in harm reduction. She brings warmth, creativity, and a hands-on approach to capacity building, always striving to foster safer, more connected communities in Western Australia.
Agenda Item Image
Mr Paul Dessauer
Chief Executive Officer
Peer Based Harm Reduction WA

Closing Remarks

4:00 PM - 4:10 PM

Paul is CEO of Peer Based Harm Reduction WA (PBHR WA), Western Australia’s only peer-based consumer-led AOD service, which provides free health and harm reduction services for people who use drugs. Paul has worked at PBHR WA for >25 years, delivering and coordinating outreach services, overdose prevention, take-home-naloxone, and peer-education projects, while providing consultancy to researchers and policy makers and workforce development to other front-line agencies. Paul has previously worked as a Drug & Alcohol Officer for the State-wide Specialist Aboriginal Mental Health Service; an educator & consultant for the Transnational Institute (in China and Myanmar); and a trainer for the Burnet Institute. Paul is committed to addressing stigmatisation directed at, improving the health equity of, and promoting the fundamental human rights of, people who use drugs. In all his work Paul strives to bring the voices and living experience of people who use drugs to research, policy, and practice.
Agenda Item Image
Dr Jodie Grigg
Research Fellow
National Drug Research Institute, Curtin University

Closing Remarks

4:00 PM - 4:10 PM

Dr Jodie Grigg is a Postdoctoral Research Fellow at the National Drug Research Institute (Curtin University, Perth) within the Harm Reduction Policy and Strategies Program. She has worked in the alcohol and other drugs (AOD) sector for almost 20 years, including around 15 years in research. While she has worked across a wide range of illicit drug projects, her work has primarily focused on drugs used in music and entertainment settings, and she is passionate about translating research into practical real-world responses that reduce harm and stigma. Jodie currently coordinates the WA arm of the Ecstasy and Related Drugs Reporting System (EDRS), part of the national Drug Trends program.
Agenda Item Image
Dr Stephen Bright
Senior Lecturer
Edith Cowan University

Closing Remarks

4:00 PM - 4:10 PM

Dr Stephen Bright is a psychologist who has worked in the AOD field for over 20 years. He is currently Senior Lecturer at Edith Cowan University where he oversees the teaching of the Addiction Studies major. Dr Bright is also WA Assistant Commissioner for AOD. Stephen is a strong advocate of harm reduction and an evidence-based approach to AOD legislation. He has published research on the intersect between new and emerging drugs and drug policy, older adults and AOD, drug checking and psychedelic-assisted psychotherapies. Dr Bright established Australia’s first not-for-profit psychedelic research company, Psychedelic Research in Science & Medicine Ltd. He has since conducted clinical trials using MDMA and psilocybin to treat treatment refractory PTSD and depression, respectively. Given the recent changes to authorised prescribers’ scheme in Australia, Stephen now trains clinicians in the provision of psychedelic-assisted psychotherapies and consultancy to prospective authorised prescribers.
Agenda Item Image
Prof Suzanne Nielsen
Professor And Deputy Director, Monash Addiction Research Centre
Monash University

APSAD President Closing Remarks

4:10 PM - 4:20 PM

Professor Suzanne Nielsen (BPharm BPharmSc[Hons] PhD MPS FANZCAP (AddMed, Research)) is the Deputy Director of the Monash Addiction Research Centre (Monash University), and a registered pharmacist with extensive experience in the area of drug treatment and harm reduction. Suzi is passionate about improving treatment for opioid dependence. Over her career she has worked on clinical guidelines, supported policy change and is currently working on established new medicines and models of care aimed at increasing access to quality evidence-based treatment.
APSAD 2026

Invitation to APSAD 2027

4:20 PM - 4:30 PM


Chair

Agenda Item Image
Stephen Bright
Senior Lecturer
Edith Cowan University

Agenda Item Image
Paul Dessauer
Chief Executive Officer
Peer Based Harm Reduction WA

Agenda Item Image
Jodie Grigg
Research Fellow
National Drug Research Institute, Curtin University

Agenda Item Image
Grace Oh
Director
Australian Drug Education & Consultancy

loading